Evidence map›Paper›PMID 35422094›Full record

ArticleLeukemia2022

CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITD

Serena Travaglini, Tiziana Ottone, Daniela Francesca Angelini, Valentina Fiori, Sabrina Dominici, Nelida Ines Noguera, Martyna Śniegocka, Silvia Antonelli, Maria Antonietta Irno Consalvo, Marco De Bardi and 13 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Serena Travaglini *Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Tiziana Ottone *Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Daniela Francesca AngeliniSanta Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy.ORCID http://orcid.org/0000-0003-4552-9226
Valentina FioriDiatheva srl, 61030, Pesaro-Urbino, Italy.
Sabrina DominiciDiatheva srl, 61030, Pesaro-Urbino, Italy.
Nelida Ines NogueraDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0001-7682-862X
Martyna ŚniegockaDepartment of Anatomy, Histology, Forensic Medicine and Orthopedic, Section of Histology, Sapienza University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0001-5389-6419
Silvia AntonelliDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Maria Antonietta Irno ConsalvoDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Marco De BardiSanta Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy.ORCID http://orcid.org/0000-0001-8217-970X
Cristina BanellaSanta Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy.
Mariadomenica DivonaDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Francesco MarchesiHematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.ORCID http://orcid.org/0000-0001-6353-2272
Silvia MasciarelliDepartment of Anatomy, Histology, Forensic Medicine and Orthopedic, Section of Histology, Sapienza University of Rome, Rome, Italy.
Francesco FaziDepartment of Anatomy, Histology, Forensic Medicine and Orthopedic, Section of Histology, Sapienza University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0003-2910-7912
Marco PieraccioliDepartment of Neuroscience, Section of Human Anatomy, Catholic University of the Sacred Hearth, Rome, Italy.ORCID http://orcid.org/0000-0003-3995-535X
Raffaele PalmieriDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0003-2855-8121
Gottardo De AngelisDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Francesco BuccisanoDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Adriano VendittiDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0002-0245-0553
Luca BattistiniSanta Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy.ORCID http://orcid.org/0000-0002-6488-4891
Mauro MagnaniDiatheva srl, 61030, Pesaro-Urbino, Italy.ORCID http://orcid.org/0000-0001-6456-6626
Maria Teresa VosoDepartment of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy. Voso@med.uniroma2.it.ORCID http://orcid.org/0000-0002-6164-4761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, Acute12E7 Antigenfms-Like Tyrosine Kinase 3HumansMutationNuclear ProteinsStem Cells12E7 AntigenCD99 protein, humanFLT3 protein, humanfms-Like Tyrosine Kinase 3Nuclear Proteins

Identifiers

PMID35422094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.